ArticleExperimental and therapeutic medicine2021

Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.

Lihui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.